TINTIN Trial

Physician initiated, prospective, non-randomized multicenter trial, investigating the safety and efficacy of the Treatment with the lumINor DCB and The IVolutioN stent of iVascular in TASC C and D femoropopliteal atherosclerotic disease.

Device: luminor 18, luminor 35 and  iVolution.

Number of patients: 100

Type of lesion: Long femoropopliteal lesions TASC C & D

Follow up: 12-month

Dr Koen Deloose (LINC 2020)

luminor and iVolution have shown in different studies that they are highly effective in long and complex long-term injuries. The combination of both is the key to success in complex injuries.

Dr Koen Deloose (LINC 2019)

Dr. Koen Deloose, A.Z. Sint-Blasius Hospital (Dendermonde, BE)

All Clinicals Trials
EVOLUTION Trial
LUMINOR Registry
EFFPAC Trial
MERLION Trial
BIBLIOS Trial